Search Results for: Respiratory

2697 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
NDUFV3 and PCNT NADH:ubiquinone oxidoreductase subunit V3 pericentrin
  • Respiratory electron transport
  • Complex I biogenesis
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • NADH
  • Ubidecarenone
  • Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II)
  • Seckel syndrome
NEDD4 and SFTPC NEDD4 E3 ubiquitin protein ligase surfactant protein C
  • ISG15 antiviral mechanism
  • Downregulation of ERBB4 signaling
  • Regulation of PTEN localization
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Surfactant metabolism
  • Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)
  • Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)
  • Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
  • Pulmonary surfactant metabolism dysfunction (SMDP)
NPM1 and UQCRH nucleophosmin 1 ubiquinol-cytochrome c reductase hinge protein
  • Nuclear import of Rev protein
  • Nuclear import of Rev protein
  • SUMOylation of transcription cofactors
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
  • Respiratory electron transport
  • Artenimol
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole
  • METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
  • (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE
  • FAMOXADONE
  • METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
  • 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
  • UBIQUINONE-2
NRF1 and PPARGC1A nuclear respiratory factor 1 PPARG coactivator 1 alpha
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Transcriptional activation of mitochondrial biogenesis
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • SUMOylation of transcription cofactors
  • Circadian Clock
  • Circadian Clock
  • Regulation of RUNX2 expression and activity
  • Regulation of RUNX2 expression and activity
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
PIK3CD and PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
  • PIP3 activates AKT signaling
  • Synthesis of PIPs at the plasma membrane
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • RET signaling
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Interleukin receptor SHC signaling
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • GPVI-mediated activation cascade
  • Synthesis of PIPs at the plasma membrane
  • G beta:gamma signalling through PI3Kgamma
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Caffeine
  • XL765
  • 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE
  • Copanlisib
  • Staurosporine
  • Myricetin
  • LY-294002
  • Quercetin
  • 5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE
  • XL765
  • 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE
  • N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE
  • 5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one
  • 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
  • (5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
  • 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
EXOSC10 and FOXRED1 exosome component 10 FAD dependent oxidoreductase domain containing 1
  • Major pathway of rRNA processing in the nucleolus and cytosol
PPBP and NDUFB11 pro-platelet basic protein NADH:ubiquinone oxidoreductase subunit B11
  • Platelet degranulation
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Neutrophil degranulation
  • Respiratory electron transport
  • Complex I biogenesis
  • Ethanesulfonic Acid
  • Copper
HTRA1 and COX5A HtrA serine peptidase 1 cytochrome c oxidase subunit 5A
  • Degradation of the extracellular matrix
  • TP53 Regulates Metabolic Genes
  • Respiratory electron transport
  • Cholic Acid
  • N-Formylmethionine
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
RAB3A and ECSIT RAB3A, member RAS oncogene family ECSIT signaling integrator
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • GABA synthesis, release, reuptake and degradation
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • Complex I biogenesis
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88 cascade initiated on plasma membrane
RAC1 and NOXA1 Rac family small GTPase 1 NADPH oxidase activator 1
  • GPVI-mediated activation cascade
  • PIP3 activates AKT signaling
  • Signaling by SCF-KIT
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Nef and signal transduction
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • DAP12 signaling
  • FCERI mediated MAPK activation
  • DSCAM interactions
  • CD28 dependent Vav1 pathway
  • EPHB-mediated forward signaling
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • PCP/CE pathway
  • Sema4D mediated inhibition of cell attachment and migration
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • Activation of RAC1
  • Inactivation of CDC42 and RAC1
  • VEGFA-VEGFR2 Pathway
  • Signal transduction by L1
  • VEGFR2 mediated vascular permeability
  • RHO GTPases activate PKNs
  • RHO GTPases activate CIT
  • RHO GTPases activate CIT
  • RHO GTPases activate KTN1
  • RHO GTPases activate IQGAPs
  • RHO GTPases activate PAKs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate Formins
  • RHO GTPases Activate Formins
  • RHO GTPases Activate NADPH Oxidases
  • MAPK6/MAPK4 signaling
  • Neutrophil degranulation
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • MET activates RAP1 and RAC1
  • NTRK2 activates RAC1
  • Activated NTRK2 signals through CDK5
  • Activation of RAC1 downstream of NMDARs
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • WNT5:FZD7-mediated leishmania damping
  • Factors involved in megakaryocyte development and platelet production
  • RHO GTPases Activate NADPH Oxidases
  • WNT5:FZD7-mediated leishmania damping
  • Dextromethorphan
  • Azathioprine
  • Guanosine-5'-Diphosphate
RAC2 and NOXA1 Rac family small GTPase 2 NADPH oxidase activator 1
  • GPVI-mediated activation cascade
  • ROS and RNS production in phagocytes
  • PIP3 activates AKT signaling
  • Rho GTPase cycle
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • PCP/CE pathway
  • RHO GTPases Activate NADPH Oxidases
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • RHO GTPases Activate NADPH Oxidases
  • WNT5:FZD7-mediated leishmania damping
  • Dextromethorphan
  • Leukocyte adhesion deficiency (LAD), including the following four diseases: Leukocyte adhesion deficiency (I); Leukocyte adhesion deficiency (II); Leukocyte adhesion deficiency (III); LAD with Rac2 deficiency
REL and TTC19 REL proto-oncogene, NF-kB subunit tetratricopeptide repeat domain 19
  • Activation of NF-kappaB in B cells
  • Hodgkin lymphoma
REL and NDUFAF3 REL proto-oncogene, NF-kB subunit NADH:ubiquinone oxidoreductase complex assembly factor 3
  • Activation of NF-kappaB in B cells
  • Complex I biogenesis
  • Hodgkin lymphoma
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
RELB and UQCRFS1 RELB proto-oncogene, NF-kB subunit ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CD209 (DC-SIGN) signaling
  • NIK - noncanonical NF-kB signaling
  • Respiratory electron transport
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole
  • METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
  • 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE
  • (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE
  • FAMOXADONE
  • METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
  • 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
  • UBIQUINONE-2
SAFB and CYCS scaffold attachment factor B cytochrome c, somatic
  • SUMOylation of transcription cofactors
  • Release of apoptotic factors from the mitochondria
  • Formation of apoptosome
  • Activation of caspases through apoptosome-mediated cleavage
  • SMAC (DIABLO) binds to IAPs
  • SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes
  • Transcriptional activation of mitochondrial biogenesis
  • Detoxification of Reactive Oxygen Species
  • TP53 Regulates Metabolic Genes
  • Respiratory electron transport
  • Regulation of the apoptosome activity
  • Regulation of the apoptosome activity
  • Minocycline
  • Protoporphyrin Ix Containing Co
  • Heme C
  • Imidazole
  • Protoporphyrin Ix Containing Zn
  • N-Trimethyllysine
  • Zinc Substituted Heme C
  • Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
ATXN1 and TTC19 ataxin 1 tetratricopeptide repeat domain 19
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
SDHB and XRN1 succinate dehydrogenase complex iron sulfur subunit B 5'-3' exoribonuclease 1
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • mRNA decay by 5' to 3' exoribonuclease
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • Succinic acid
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • UBIQUINONE-1
SDHB and SPRY2 succinate dehydrogenase complex iron sulfur subunit B sprouty RTK signaling antagonist 2
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • Spry regulation of FGF signaling
  • EGFR downregulation
  • Succinic acid
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • UBIQUINONE-1
SDHB and CARTPT succinate dehydrogenase complex iron sulfur subunit B CART prepropeptide
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • Succinic acid
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • UBIQUINONE-1
  • Amphetamine
SDHB and PIK3R5 succinate dehydrogenase complex iron sulfur subunit B phosphoinositide-3-kinase regulatory subunit 5
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • GPVI-mediated activation cascade
  • Synthesis of PIPs at the plasma membrane
  • G beta:gamma signalling through PI3Kgamma
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Succinic acid
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • UBIQUINONE-1

Page 15 out of 135 pages